Phase II study of lenalidomide for the treatment of relapsed or refractory Hodgkin's lymphoma
Phase of Trial: Phase II
Latest Information Update: 25 Jun 2016
At a glance
- Drugs Lenalidomide (Primary) ; Dexamethasone
- Indications Hodgkin's disease
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 15 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 07 Jun 2012 Planned end date changed from 1 Sep 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.